| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.417 | 10.125 | 8.067 | - | 4.642 | 8.368 | 7.549 |
| Total Income - EUR | - | - | - | 3.417 | 10.125 | 8.067 | - | 4.656 | 16.557 | 14.958 |
| Total Expenses - EUR | - | - | - | 3.400 | 11.818 | 6.214 | - | 5.485 | 14.844 | 10.259 |
| Gross Profit/Loss - EUR | - | - | - | 17 | -1.694 | 1.853 | - | -829 | 1.713 | 4.699 |
| Net Profit/Loss - EUR | - | - | - | -17 | -1.729 | 1.839 | - | -909 | 1.599 | 4.624 |
| Employees | - | - | - | 0 | 2 | 2 | - | 1 | 2 | 1 |
Check the financial reports for the company - Prorelax Therapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 169 | 165 | - | 3.508 | 3.497 | 3.478 |
| Current Assets | - | - | - | 637 | 562 | 2 | - | 56 | 866 | 3.457 |
| Inventories | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 539 | 0 | - | 0 | 0 | 0 |
| Cash | - | - | - | 637 | 23 | 2 | - | 56 | 866 | 3.457 |
| Shareholders Funds | - | - | - | 26 | -1.704 | 167 | - | -746 | 856 | 5.474 |
| Social Capital | - | - | - | 43 | 42 | 41 | - | 41 | 40 | 40 |
| Debts | - | - | - | 611 | 2.435 | 0 | - | 4.310 | 3.508 | 1.461 |
| Income in Advance | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Prorelax Therapy Srl